Cough Symptomatic Treatment in Adults

Khimion L.V., D. of M.S., professor, Yaschenko O.B. C. of M.S., Danulyk S.V. C. of M.S., Sutyk T.O. C. of M.S.

P.L. Shupyk National Medical Academy of Postgraduate Education

The choice of medicinal products which affect the different characteristics of cough should be determined by the fact that cough – is not nosological unit, but is a symptom of various diseases that is why, treatment of cough itself, should be symptomatic, differentiated and retain protective physiological mechanisms of cough.

PulmoBREATHE® MoviHealth, Switzerland - a unique in its combination multipurpose medicinal product is currently on pharmaceutical market of Ukraine. It is the only patented combination of acetyl cysteine ​​and ambroxol hydrochloride in Ukraine. Due to multipurpose action, each component of medicinal product supplements strengthens mucolytic and mucokinetic action of each other. Use of PulmoBREATHE® medicinal product is justified in the complex treatment of acute and chronic respiratory diseases with disorder of secretions formation and evacuation.

In case of allergic component inclusion to MCC disorder, that is combination of viral-bacterial and allergic inflammation, the appropriate treatment is use of PulmoLOR® MoviHealth, Switzerland medicinal product - combination of loratadine and ambroxol hydrochloride.

The choice of medicinal products used for cough, should be done taking into account the nature of cough, duration and key elements in pathogenesis of its development. In this case recommended medicinal products should have a sufficient level of efficiency in accordance with the principles of evidence-based medicine and to be safe.